Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0283 has been discontinued.
View all Non-selective Ionotropic Glutamate products.Synthetic analogue of the polyamine amide toxin found in the venom of the Digger Wasp. Blocks cation channels gated by glutamate and acetylcholine in mammalian and invertebrate neurones.
M. Wt | 544.99 |
Storage | Desiccate at +4°C |
CAS Number | 115976-93-7 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Donevan and Rogawski (1996) Mutiple actions of arylalkylamino arthropod toxins on the NMDA receptor. Neuroscience 70 361 PMID: 8848146
Eldefrawi et al (1988) Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. Proc.Natl.Acad.Sci.U.S.A. 85 4910 PMID: 2838850
Green et al (1996) Polyamine amides are neuroprotective in cerebellar granule cell cultures challenged with excitatory amino acids. Brain Res. 717 135 PMID: 8738263
Keywords: Philanthotoxin 343 trihydrochloride, Philanthotoxin 343 trihydrochloride supplier, Non-selective, Ionotropic, Glutamate, 0283, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Philanthotoxin 343 trihydrochloride.
There are currently no reviews for this product. Be the first to review Philanthotoxin 343 trihydrochloride and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.